matrix include the construct of acute threat, which can be measured on a physiological level using potentiation of the acoustic startle reflex assessed via electromyography recordings of the orbicularis oculi muscle. Impairments in extinction of fear-potentiated startle due to high levels of fear (termed fear load) during the early phases of extinction have been observed in posttraumatic stress disorder (PTSD). The goals of the current work were to examine dimensional associations between fear-related symptoms of PTSD and fear load variables to test their validity as an intermediate phenotype. We examined extinction of fear-potentiated startle in a cohort (n = 269) of individuals with a broad range of civilian trauma exposure (range 0-13 traumatic events per person, mean = 3.5). Based on previously reported findings, we hypothesized that fear load would be significantly associated with intrusion and fear memories of an index traumatic event. The results indicated that early extinction was correlated with intrusive thoughts (p = 0.0007) and intense physiological reactions to trauma reminders (p = 0.036). Degree of adult or childhood trauma exposure, and depression severity were not associated with fear load. After controlling for age, sex, race, income, level of prior trauma, and level of fear conditioning, fear load during extinction was still significantly predictive of intrusive thoughts (p = 0.004). The significance of these findings is that they support dimensional associations with symptom severity rather than diagnostic category and, as such, fear load may emerge as a transdiagnostic intermediate phenotype expressed across fear-related disorders (e.g., specific phobia, social phobia).
Introduction
A primary objective of the Research Domain Criteria (RDoC) project, initiated by the National Institute of Mental Health in 2008, is to develop psychiatric disease classifications according to the integration of observable, quantifiable neuroscientific and behavioral indices as opposed to phenomenological descriptors. This includes the identification and characterization of neurobiological intermediate phenotypes that provide dimensional correlates of psychopathology (Insel et al., 2010; Cuthbert, 2014) . Ideally, these phenotypes would transcend diagnostic categories and represent fundamental neurobiological mechanisms underlying common clinical presentations of mental illness. Recent work from our group and others has explored psychophysiological measures of conditioned fear expression as an observable intermediate phenotype of fear-related symptoms common to trauma-, stressor, and anxiety-related disorders (for reviews see Johnson et al., 2012; Briscione et al., 2014) .
The Negative Valence Systems in the RDoC matrix include the construct of acute threat or fear, which can be measured on a physiological level using potentiation of the acoustic startle reflex. Fear-potentiated startle is defined as the increase in the frequency or magnitude of the acoustic startle reflex in the presence of a previously neutral stimulus that has been repeatedly paired with an aversive unconditioned stimulus (Davis, 1992; Davis et al., 1993) . Extinction of fear-potentiated startle has been extensively examined in recent years both in healthy populations (Norrholm et al., 2006 (Norrholm et al., , 2008 and in traumatized civilian and combat populations. Impairments in extinction of fear-potentiated startle due to high levels of conditioned fear expression (termed fear load) during the early phases of extinction have been observed in posttraumatic stress disorder (PTSD; . Recent studies suggest that contributing factors to an individual's fear load include, but are not limited to, symptom severity in the aftermath of trauma (e.g., reexperiencing; , genomics (e.g., catechol-Omethyl-transferase, COMT Val66Met polymorphism and methylation; Norrholm et al., 2013) , and activational effects of hormones levels (e.g., estrogen; Glover et al., 2012) . Fear load is also positively correlated with attention bias to threat suggesting common underlying neural circuitry (Fani et al., 2012) . Although the focus of the current work was on a traumatized civilian population and the severity of their symptoms according to a self-reported PTSD scale (PTSD Symptom Scale, PSS, Falsetti et al., 1993) , recent work has suggested that psychophysiological fear load may be evident in other mental disorders whose clinical presentation includes the over-expression of more complex fear behaviors (e.g., specific phobia, social phobia; Waters et al., 2014) .
Fear-potentiated startle techniques have been employed in translational models of stressor-and trauma-induced behavioral responses in numerous studies across rodent and primate species (Rothbaum and Davis, 2003) . This is in large part due to the conservation of the fundamental neural circuitry underlying fear expression as the model species advances phylogenetically as well as the high degree of consistency afforded by the methodologies used to observe and quantify startle responses. From a clinical perspective, empirical evidence suggests that common neural systems underlie (1) the acquisition and extinction of associations between a conditioned stimulus (CS) and an aversive unconditioned stimulus (US) with which it is paired and (2) the development, maintenance, and suppression of traumatic memories, or intrusive thoughts Jovanovic and Norrholm, 2011; VanElzakker et al., 2014) . Briefly, for fear acquisition, these systems include the convergence of the sensory properties of a conditioned stimulus (e.g., laboratory: geometric shape; experiential: ambient environmental cues) with the aversive properties of an unconditioned stimulus (laboratory: cutaneous shock; experiential: traumatic experience) within the basolateral amygdala and subsequent projections to the central amygdala and its hypothalamic and brainstem targets (Davis, 1992) . The role of the amygdala in fear conditioning and extinction has been well characterized in animal studies (Davis et al., 1995 and in human neuroimaging studies (Phelps et al., 2004) . In addition, a very recent review by Weston (2014) highlights at least 14 human posttraumatic responses that are primarily governed by the amygdaloid complex (Weston, 2014) . Further, a large body of evidence supports an inhibitory role of higher cortical regions such as the medial prefrontal cortex on amygdala-based fear expression during fear extinction in rodents and humans (Phelps et al., 2004; Quirk and Beer, 2006; Shin et al., 2006; Milad et al., 2007) . Taken together, this body of empirical literature highlights the interaction between the amygdala and cortical regions such as prefrontal cortex as a conserved underlying neural system that mediates fear learning and extinction and, in clinical cases, the manifestation of quantifiable neurobiological measures.
The "neural systems" approach was discussed by Davis (1992) and later re-visited by LeDoux (2012) in an effort to guide translational and clinical investigations away the limitations of diagnostic categories and the anthropomorphizing of animal subjects and toward approaches such as that suggested by the RDoC initiative (LeDoux, 2012) . For example, rather than attempting to model human mental disorders including PTSD in rodent models, LeDoux (2012) suggests the identification of common systems that are phylogenetically conserved such as those that mediate an organism's stimulus specific responses (e.g., fear rather than more generalized anxiety). As such, a primary objective of the current study was to examine dimensional associations between fearrelated symptoms of PTSD and fear load variables to test their validity as an intermediate phenotype. Based on previously reported findings, we hypothesized that fear load would be specifically associated with intrusion and fear memories of an index traumatic event. In addition, we discuss the current results with respect to the possibility that fear load represents a transdiagnostic, core feature of fear-related disorders that is expressed across DSM-5 diagnostic categories.
Methods

Participants
The study included 269 participants who were recruited from the general medical clinics of Grady Hospital in Atlanta, GA. Inclusion criteria were willingness to participate and ability to understand the informed consent form. Exclusion criteria included active psychosis and major medical illnesses as assessed by history and physical examinations conducted by licensed physicians. Participants were also excluded for urine toxicology that was positive for cocaine and screened for hearing impairment with an audiometer (Grason-Stadler, Model GS1710). All subjects were able to detect tones at 30 dB (A) SPL at frequencies ranging from 250 to 4000 Hz. Prior to their participation, all participants provided written informed consents approved by the Emory University Institutional Review Board and Grady Research Oversight Committee.
Assessment
We assessed PTSD symptoms using the Modified PTSD Symptom Scale (PSS), which is a self-report measure of symptom severity during the last two weeks on 17 items (Falsetti et al., 1993) . Trauma exposure was assessed using the Traumatic Events Inventory (Gillespie et al., 2009 ) which catalogs exposure to 14 criterion events, including childhood physical and sexual abuse. These instruments have been validated in this population (Binder et al., 2008; Gillespie et al., 2009 ).
Fear conditioning paradigm
The fear-potentiated startle protocol consisted of two phases: Fear Acquisition and Fear Extinction. The Fear Acquisition phase began with a habituation phase in which the CSs were presented without any reinforcement; the conditioning phase consisted of three blocks with four trials of each type (a reinforced conditioned stimulus, CS+; a nonreinforced conditioned stimulus, CS−; and the 40 ms, 108 dB noise probe alone, NA) for a total of 12 trials per block and 36 total trials. Both CSs were colored shapes presented on a computer monitor for 6 s. The US was a 250-ms airblast with an intensity of 140 psi directed at the larynx. This US has been used in several of our previous studies and consistently produces robust fearpotentiated startle. In all phases, the inter-trial intervals were randomized to be 9 to 22 s in duration. Ten minutes after the Fear Acquisition phase, participants underwent the Fear Extinction phase. The Extinction phase consisted of 6 blocks with four trials of each type (the previously reinforced CS+, CS−, and NA) for a total of 12 trials per block and 72 total trials. None of the CS presentations during Extinction was reinforced with an airblast US.
As in our previous work (Jovanovic et al., 2005 (Jovanovic et al., , 2009 Norrholm et al., 2006 Norrholm et al., , 2008 , the eyeblink component of the acoustic startle response was measured by EMG recordings of the right orbicularis oculi muscle with two 5-mm Ag/AgCl electrodes filled with electrolyte gel. One electrode was positioned 1 cm below the pupil of the right eye and the other was placed 1 cm below the lateral canthus. Impedance levels were less than 6 kilo-ohms for each participant. The startle probe was a 108-dB (A) SPL, 40-ms burst of broadband noise with near instantaneous rise time, delivered binaurally through headphones.
The startle response data were acquired using the electromyography (EMG) module of the BIOPAC MP150 for Windows (Biopac Systems, Inc., Aero Camino, CA). The acquired data were filtered, rectified, and smoothed using the MindWare software suite (MindWare Technologies, Ltd., Gahanna, OH) and exported for statistical analyses. The EMG signal was sampled at a frequency of 1 kHz and filtered with low-and high-frequency cutoffs at 28 and 500 Hz, respectively. The maximum amplitude of the eyeblink muscle contraction 20-200 ms after presentation of the startle probe was used as a measure of the acoustic startle response. As in our previous studies (e.g. Norrholm et al., , 2013 , we did not code low responses as zeros, but used all amplitude values.
Data analysis
Fear-potentiated startle was calculated using a Difference Score by subtracting startle magnitude to the noise probe alone (NA) from startle magnitude in the presence of a CS in each conditioning block. These variables were analyzed in a mixed ANOVA with the within-subject factor of Block (3 levels for Fear Acquisition; 6 levels for Fear Extinction) and trial type (2 levels, CS + and CS−). Late Fear Acquisition was defined as block 3 of acquisition, when discrimination learning was at maximum; Extinction was divided into 3 phases: early (blocks 1 and 2), mid (blocks 3 and 4), and late (blocks 5 and 6) extinction.
Rather than grouping the subjects by PTSD diagnosis, we examined the symptoms along a dimension from low to severe in order to be consistent with the RDoC approach. We first examined correlations between continuous symptom severity and fear-potentiated startle variables during fear acquisition and extinction. For significant correlations (those that survived Bonferroni correction for multiple comparisons), we performed a stepwise linear regression analysis controlling for demographic information and degree of trauma exposure. Finally, in order to test for possible non-linear effects, we performed a univariate analysis of variance (ANOVA) with symptom category as the independent variable. The categorical variable was defined using the participants' responses for the items, which had 4 levels: "not at all/only once", "once per week", "2-4 times per week", and "5 or more times per week/almost always". All statistical analyses were performed in SPSS 17.0 for Windows (SPSS, Inc., Chicago, IL), with alpha set at 0.05.
Results
Participant descriptives
The participant sample was primarily African American (92.5%) and female (66.0%). The participants were on average 40.02 years old (range 18 to 66). The majority of participants reported being unemployed (78.5%), with 72.5% of the sample earning less than $1000 per month. Table 1 shows the clinical information for the study sample. The participants were highly traumatized, with the average number of Criterion A trauma types experienced being 3.53 (SD = 2.50, range 0 to 13). The average total PSS was 14.78 (SD = 12.50).
Fear conditioning and extinction
A repeated measures ANOVA of Block by Trial Type (CS+, CS−) during Acquisition showed significant main effects of Block, F(2, 536) = 76.40, p b 0.001, main effect of Trial Type, F(1, 268) = 20.13, p b 0.001, and an interaction of the two variables, F(2, 536) = 21.46, p b 0.001, see Table 2 . The interaction effect was due to the discrimination between the CS + and CS − increasing over blocks, so that fear-potentiated startle was much higher to the CS + than the CS − during the last two blocks, termed Late Acquisition, F(1, 268) = 36.30, p b 0.001. A repeated measures ANOVA of Block by Trial Type during Extinction showed a significant main effect of Block, F(5, 1330) = 105.78, p b 0.0001, but no main or interaction effects with Trial Type. Table 2 shows the means and standard deviations for fear-potentiated startle during Acquisition and Extinction. In order to reduce the number of variables in the subsequent analyses and focus on CS+ extinction, we collapsed the blocks into three phases (Early, Mid, Late). Fearpotentiated startle to the CS + showed a significant decrease during the three phases of extinction F(2, 536) = 106.01, p b 0.0001.
Symptoms and fear extinction
We examined correlations between Early, Mid and Late extinction with the three primary symptoms clusters based on the DSM-IV, i.e. Re-experiencing, Avoidance and Hyperarousal symptoms, and found that fear-potentiated startle during Early and Mid Extinction was positively correlated with Re-experiencing symptoms (r = 0.12, p = 0.05, and r = 0.16, p = 0.01, respectively). In order to further examine the fear-related symptoms, we specifically queried the association between fear extinction and the following items on the PSS: 1) frequency of Table 3 Correlations between individual fear-related items from the PSS and fear extinction. The bold font associations that remained significant after correction for multiple comparisons. The bold font associations that remained significant after correction for multiple comparisons.
Correlations
intrusive distressing thoughts, 2) frequency of intense emotional upset at reminders, and 3) frequency of intense physical reaction to reminders. In addition we included the item on 4) frequency of startle response to examine the association between self-reported startle and EMG measures of fear-potentiated startle response. In order to correct for multiple comparisons (12 correlations: 3 startle variables × 4 PSS items), we used a p = 0.004 as the threshold for a significant correlation. Table 3 shows the correlations between these variables. As can be seen, two associations remained significant after p-value correction: frequency of intrusive distressing thoughts was correlated with Early Extinction, r = 0.21, p = 0.0007, and Mid Extinction, r = 0.20, p = 0.001. Of note, there was no association between self-reported startle and EMG startle. In order to control for demographic data and trauma history, we performed stepwise linear regressions, adding age, sex, race, and income in the first step, trauma exposure in the second step, and either Early or Mid Extinction in the final step predicting intrusive symptoms. While these covariates were not significantly associated with fear load (FPS during Early and Mid Extinction), they were included in a regression in order to see whether FPS would mediate potential associations between these variables and intrusive symptoms. The final model for Early Extinction was significant, F(6, 244) = 6.35, p b 0.001, and accounted for 13.8% of the variance in intrusive symptoms, with FPS alone accounting for 5.2% of the variance after controlling for demographics and trauma history, F change (1, 238) = 14.46, p b 0.0001. Similarly, the regression for Mid Extinction was significant, F(6, 244) = 5.79, p b 0.001 and accounted for 12.7% of the variance in intrusive symptoms, with FPS alone accounting for 4.2% of the variance, F change (1, 238) = 11.41, p = 0.001.
Given that Early Extinction is highly correlated with level of fear at the end of acquisition (r = 0.46, p b 0.001), we included fearpotentiated startle to CS + during Late Acquisition to the model, and Early Extinction was still significantly predictive of intrusive symptoms, F change (1, 237) = 12.23, p = 0.001. Of the covariates entered into the model, only female sex (p = 0.04) and higher trauma exposure (p b 0.001) were predictive of higher frequencies of intrusive thoughts. Table 4 shows the beta coefficients for each variable. As shown in the table, fear-potentiated startle at the end of Acquisition did not contribute to intrusive thoughts. These results suggest that fear responses during extinction were associated with psychopathology above and beyond the original level of fear conditioning, i.e. the excessive fear load during extinction was not due to heightened fear conditioning. Importantly, it was also not predicted by age, race, or low income, suggesting that it may generalize to other traumatized populations.
In order to test for non-linear effects of symptom severity, we performed a univariate ANOVA comparing the participants across four categories of reported symptom frequency on FPS during extinction: "not at all/only once", "once per week", "2-4 times per week", and "5 or more times per week/almost always". Fig. 1 shows FPS for each category during Early Extinction (1A) and Mid Extinction (1B). There was a significant main effect of symptom frequency category on Early Extinction, F(3, 254) = 4.77, p = 0.003, and post-hoc tests indicated that the most severe category (5 or more times per week) was significantly higher than all other categories, 0.0002 b p b 0.03 (Fig. 1A) . While there was a main effect of category on Mid Extinction as well, F(3, 254) = 3.83, p = 0.01, post-hoc tests showed that the most severe category differed only from the lowest frequency category, p = 0.001 (Fig. 1B) . These data suggest that there may be a threshold in symptom frequency in that those with 5 or more symptoms per week have higher physiological fear than those with up to 4 symptoms per week. In this sample, the extreme symptom group represented about 13% of the entire sample-these individuals have the highest fear load and resistance to extinction.
Discussion
The primary findings of the current study demonstrate that the early phase of conditioned fear extinction, during which time the fear load phenomenon is observed, is significantly correlated with intrusive thoughts (p = 0.0007) and intense physiological reactions to trauma reminders (p = 0.036). In addition, the degree of adult or childhood trauma exposure was not associated with fear load. Further, fear load during extinction training remained significantly predictive of intrusive thoughts (p = 0.004) after statistically controlling for the factors of age, sex, race, income, level of prior trauma, and level of fear conditioning. The individuals with the most severe symptoms (with a frequency of 5 or more intrusive thoughts per week), had significantly greater fear-potentiated startle during early extinction than all other patients, including those who reported having symptoms 2-4 times per week, p = 0.02.
The present study extends our previous research in two important ways: first, we have further characterized the association between fear load and posttraumatic stress responses from a broad range of intrusive symptoms (e.g., to those specifically relating to fear memories of the traumatic event. The significance of this finding is that it points to dimensional associations with symptom severity rather than a diagnostic category, thereby aligning well with the RDoC approach (Insel et al., 2010) . Second, rather than examining only linear relationships between symptoms and fear load, we were able to observe a non-linear threshold function indicating that high fear load is primarily present in those who are extremely symptomatic and in greatest need of treatment intervention. The present study also replicated our earlier findings in a much larger dataset, demonstrating the robustness of the fear load phenotype in this civilian trauma population.
As previously noted, we also controlled for the level of fear acquisition in the regression analysis of early extinction. Due to the high correlation between these variables, it is important to test whether extinction accounts for the variance in symptoms apart from fear acquisition. We found this to be the case; early extinction significantly predicted intrusive symptoms even after accounting for level of terminal fear acquisition.
Recent studies have identified heterogeneous trajectories of fear extinction that represent exciting new avenues for developing targeted analytical and treatment methodologies in this area of study (Galatzer-Levy et al., 2013b) . Three distinct populations have been identified in rats based on their pattern of freezing response during extinction training. Patterns include a modal trajectory of rapid and complete fear extinction learning, a population who slowly but also completely extinguishes the learned fear response, and a minority of rats that fail to extinguish and continue to show high levels of fear in response to the conditioned stimulus (Galatzer-Levy et al., 2013b) . Highly concordant patterns in PTSD symptom severity have been identified among adult trauma survivors who were followed longitudinally from immediately after trauma exposure to 14 months of post-exposure (Galatzer-Levy et al., 2013a) . Importantly, these analyses indicate that these are distinct phenotypes, not one population with variability in their degree of fear response.
These distinct phenotypes indicate that mechanisms and pathways, as well as sequelae in other domains of functioning may also be heterogeneous, with different causes, consequences, and treatments being relevant to different populations. For example, early psychotherapeutic interventions following trauma exposure have been shown to only have an effect for individuals in one of the three identified PTSD trajectories (Galatzer-Levy et al., 2013a ). An important future direction will be to similarly empirically identify populations in traumatized individuals based on fear load. These populations may better inform our understanding of underlying neurobiological processes that lead to healthy and abnormal fear learning. Further, the effectiveness of new therapeutic interventions can be determined based on their ability to alter an individual's trajectory. The RDoC approach previously described (e.g., Cuthbert, 2014; Insel et al., 2010) incorporates a Negative Valence System that includes the constructs of acute threat or fear that we now suggest can be indexed through psychophysiological units of analysis within the fear learning framework. In other words, the fear load phenomenon described here and in our previous work may serve as a common feature of fearrelated "psychopathology based on dimensions of observable behavior and neurobiological measures (Cuthbert, 2014) ." Fear load may be an intermediate phenotype that is related to the underlying etiology of fear disorders and the symptoms of fear-related psychopathologies (Briscione et al., 2014) , such as phobias (Waters et al., 2014) . Although there is little transdiagnostic work in this area, some evidence suggests that fear load phenomena are present in other fear-related disorder as well. For example, highly anxious individuals with a fear of flying have displayed greater physiological arousal to both simulated and in vivo flight-related cues (Trimmel et al., 2014) . In addition, elevated psychophysiological responses (including startle) have been reported in claustrophobic individuals exposed to a virtual tunnel environment (Mühlberger et al., 2007) . It remains to be seen if fear load manifests itself across fear-related psychiatric conditions including multiple classes of phobia.
Additionally, fear load can be modeled in pre-clinical research, such as the percentage of animals that has difficulty with fear extinction. Modeling fear load in animal studies is consistent with the approach advocated by LeDoux (2012) as it allows mechanistic neuroscientific investigation of this phenotype using an RDoC approach. Table 5 lists the suggested conditions that the fear load phenotype meets in order to qualify as a useful measure for RDoC studies.
The apparent pathological feature of excessive fear load clearly represents a potential clinical target for therapeutic intervention, however, lower levels of fear may predict more favorable outcomes. As is the case with arousal and task performance, there may be an inverted U shaped curve, in that there are optimal levels of fear than can have beneficial consequences. However, if arousal levels continue to increase, performance on difficult tasks will be impaired (for example, Yerkes-Dodson law (Diamond et al., 2007) ). For example, recent investigations have explored acoustic startle responses to trauma-related stimuli (termed trauma-potentiated startle) within the presentation of a virtual reality environment (Roy et al., 2013; Robison-Andrew et al., 2014) . RobisonAndrew et al. (2014) showed that combat veterans who responded positively to prolonged exposure therapy (e.g., N50% reduction in their CAPS score over the course of treatment) displayed an initial increase in trauma-potentiated startle that was followed by a marked decrease in startle responses to trauma-related cues. It is possible that this level of fear or arousal experienced in the virtual reality session fosters engagement with the stimuli and enhanced therapeutic effects. However, once extreme levels of fear are present, they are a hindrance to fear extinction, which requires new learning (Quirk, 2002) and significant engagement of the prefrontal cortex (Milad et al., 2007) which may be hypoactive in PTSD (Milad et al., 2009) . Even in psychiatrically healthy individuals, high levels of induced fear interfere with attention and cognitive processes (Moser et al., 2005) . In those suffering from traumarelated disorders, fear load may represent an obstacle that must be overcome in order to achieve recovery from intrusive thoughts. In fact, in some cases, patients may self-medicate with substance abuse in order to reduce fear load, leading to further psychopathology . While the present research represents a sample from a low-income, primarily African American inner-city population, these demographics did not account for the observed fear load, which suggests that the findings may generalize to other traumatized populations. There is a compelling rationale to further examine fear load as an intermediate phenotype for fear-related psychopathologies, more specifically, as a biological marker of symptom severity and as a putative predictor of treatment efficacy as well as a target for therapeutic intervention.
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